Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy

Despite the identification of an expanded CAG repeat on exon 1 of the huntingtin gene located on chromosome 1 as the genetic defect causing Huntington’s disease almost 30 years ago, currently approved therapies provide only limited symptomatic relief and do not influence the age of onset or disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurcau, Anamaria, Jurcau, Maria Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405755/
https://www.ncbi.nlm.nih.gov/pubmed/36009443
http://dx.doi.org/10.3390/biomedicines10081895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405755/
https://www.ncbi.nlm.nih.gov/pubmed/36009443
http://dx.doi.org/10.3390/biomedicines10081895

Ejemplares similares